Further research is clearly warranted to fully comprehend the interplay between gut microbiota, gut hormones, and cardiac function in HF
the Young Innovator Association of CAS (H.M.)
Role of the growth hormone-IGF-1 axis in cancer
04, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
Many patients report noticing improvements in energy, mood, and mental clarity within a few weeks, with physical changes developing over time with consistent treatment